Arrestins differentially regulate histamine- and oxytocin-evoked phospholipase C and mitogen-activated protein kinase signalling in myometrial cells

British Journal of Pharmacology

Volumn 162, Issue 7, 2011, Pages 1603-1617

  Brighton, Paul J ^a   Rana, Shashi ^a   Challiss, R A John ^a   Konje, Justin C ^a   Willets, Jonathon M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

arrestin; contractile signalling; desensitization; histamine H 1 receptor; MAPK; myometrium; oxytocin receptor

Indexed keywords

ARRESTIN2; ARRESTIN3; CALCIUM ION; HISTAMINE; HISTAMINE H1 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXYTOCIN; OXYTOCIN RECEPTOR; PHOSPHOLIPASE C; RETINA S ANTIGEN; SYNAPTOPHYSIN; UNCLASSIFIED DRUG;

ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; MYOMETRIUM; MYOMETRIUM CELL; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; RECEPTOR DOWN REGULATION; SIGNAL TRANSDUCTION;

ARRESTINS; CALCIUM; CELL LINE; FEMALE; HISTAMINE; HUMANS; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASES; MYOMETRIUM; OXYTOCIN; PHOSPHORYLATION; PROTEIN ISOFORMS; RECEPTORS, HISTAMINE H1; RECEPTORS, OXYTOCIN; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TYPE C PHOSPHOLIPASES;

EID: 79952364765     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.01173.x     Document Type: Article

References (55)

1. Ahn S, Shenoy SK, Wei H, Lefkowitz RJ, (2004a). Differential kinetic and spatial patterns of β-arrestin and G protein-mediated ERK activation by the angiotensin II receptor. J Biol Chem 279: 35518-35525. (Pubitemid 39100552)
2. Ahn S, Wei H, Garrison TR, Lefkowitz RJ, (2004b). Reciprocal regulation of angiotensin receptor-activated extracellular signal-regulated kinases by β-arrestins 1 and 2. J Biol Chem 279: 7807-7811. (Pubitemid 38294665)
3. Alexander SPH, Mathie A, Peters JA, (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158: S1-S254.
4. Ball A, Wang JW, Wong S, Zielnik B, Mitchell J, Wang N, et al. (2006). Phorbol ester treatment of human myometrial cells suppresses expression of oxytocin receptor through a mechanism that does not involve activator protein-1. Am J Physiol Endocrinol Metab 291: E922-E928.
5. Bartlett SR, Sawdy R, Mann GE, (1999). Induction of cyclooxygenase-2 expression in human myometrial smooth muscle cells by interleukin-1β: involvement of p38 mitogen-activated protein kinase. J Physiol 520: 399-406. (Pubitemid 29511904)
6. Blanks AM, Thornton S, (2003). The role of oxytocin in parturition. BJOG 110 (Suppl. 20): 46-51. (Pubitemid 36581875)
7. Bonfil D, Chuderland D, Kraus S, Shahbazian D, Friedberg I, Seger R, et al. (2004). Extracellular signal-regulated kinase, Jun N-terminal kinase, p38, and c-Src are involved in gonadotropin-releasing hormone-stimulated activity of the glycoprotein hormone follicle-stimulating hormone beta-subunit promoter. Endocrinology 145: 2228-2244. (Pubitemid 38535052)
8. Brighton PJ, McDonald J, Taylor AH, Challiss RA, Lambert DG, Konje JC, et al. (2009). Characterization of anandamide-stimulated cannabinoid receptor signaling in human ULTR myometrial smooth muscle cells. Mol Endocrinol 23: 1415-1427.
9. Brodt-Eppley J, Myatt L, (1999). Prostaglandin receptors in lower segment myometrium during gestation and labor. Obstet Gynecol 93: 89-93.
10. Bruchas MR, Macey TA, Lowe JD, Chavkin C, (2006). κ-opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes. J Biol Chem 281: 18081-18089. (Pubitemid 44035608)
11. Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE, (2003). Effect of histamine on phasic and tonic contractions of isolated uterine tissue from pregnant women. Am J Obstet Gynecol 188: 774-778. (Pubitemid 36332450)
12. 1 receptor antagonist. Am J Obstet Gynecol 191: 1356-1361. (Pubitemid 39421596)
13. Bytautiene E, Vedernikov YP, Saade GR, Romero R, Garfield RE, (2004b). Degranulation of uterine mast cell modifies contractility of isolated myometrium from pregnant women. Am J Obstet Gynecol 191: 1705-1710. (Pubitemid 39491200)
14. Conti F, Sertic S, Reversi A, Chini B, (2009). Intracellular trafficking of the human oxytocin receptor: evidence of receptor recycling via a Rab4/Rab5 'short cycle'. Am J Physiol Endocrinol Metab 296: E532-E542.
15. Devost D, Carrier ME, Zingg HH, (2008). Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C. Endocrinology 149: 131-138.
16. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK, (2007). β-arrestins and cell signaling. Annu Rev Physiol 69: 483-510.
17. Engelhardt S, Zieger W, Kassubek J, Michel MC, Lohse MJ, Brodde OE, (1997). Tocolytic therapy with fenoterol induces selective down-regulation of β-adrenergic receptors in human myometrium. J Clin Endocrinol Metab 82: 1235-1242. (Pubitemid 27166670)
18. Fuchs AR, Fuchs F, Husslein P, Soloff MS, (1984). Oxytocin receptors in the human uterus during pregnancy and parturition. Am J Obstet Gynecol 150: 734-741. (Pubitemid 15204655)
19. Gesty-Palmer D, Luttrell LM, (2008). Heptahelical terpsichory. Who calls the tune? J Recept Signal Transduct Res 28: 39-58. (Pubitemid 351588072)
20. 2-adrenergic receptors. J Biol Chem 283: 29028-29036.
21. Hasbi A, Devost D, Laporte SA, Zingg HH, (2004). Real-time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol Endocrinol 18: 1277-1286. (Pubitemid 38591291)
22. Helmer H, Hackl T, Schneeberger C, Knofler M, Behrens O, Kaider A, et al. (1998). Oxytocin and vasopressin 1a receptor gene expression in the cycling or pregnant human uterus. Am J Obstet Gynecol 179: 1572-1578. (Pubitemid 29028403)
23. i in single human myometrium smooth muscle cells. Cell Calcium 20: 43-51. (Pubitemid 26278934)
24. Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, et al. (2005). Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102: 1442-1447. (Pubitemid 40209189)
25. 2- adrenergic receptor. J Biol Chem 269: 13084-13087.
26. q/11. Endocrinology 136: 1509-1515.
27. Luttrell LM, Lefkowitz RJ, (2002). The role of β-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci 115: 455-465. (Pubitemid 34182973)
28. Massey WA, Guo CB, Dvorak AM, Hubbard WC, Bhagavan BS, Cohan VL, et al. (1991). Human uterine mast cells. Isolation, purification, characterization, ultrastructure, and pharmacology. J Immunol 147: 1621-1627.
29. 2α receptor genes are expressed in human myometrium and are down-regulated during pregnancy. Biochem Biophys Res Commun 238: 838-841. (Pubitemid 27472662)
30. Molnar M, Rigo J, Jr, Romero R, Hertelendy F, (1999). Oxytocin activates mitogen-activated protein kinase and up-regulates cyclooxygenase-2 and prostaglandin production in human myometrial cells. Am J Obstet Gynecol 181: 42-49. (Pubitemid 29343329)
31. 2+ signaling in single resistance arterial smooth muscle cells. Am J Physiol Cell Physiol 295: C1590-C1601.
32. Oakley RH, Laporte SA, Holt JA, Barak LS, Caron MG, (2001). Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-β-arrestin complexes after receptor endocytosis. J Biol Chem 276: 19452-19460.
33. Olson DM, Zaragoza DB, Shallow MC, Cook JL, Mitchell BF, Grigsby P, et al. (2003). Myometrial activation and preterm labour: evidence supporting a role for the prostaglandin F receptor-a review. Placenta 24: S47-S54. (Pubitemid 37184734)
34. Perez-Reyes N, Halbert CL, Smith PP, Benditt EP, McDougall JK, (1992). Immortalization of primary human smooth muscle cells. Proc Natl Acad Sci U S A 89: 1224-1228.
35. Phaneuf S, Asboth G, Carrasco MP, Europe-Finner GN, Saji F, Kimura T, et al. (1997). The desensitization of oxytocin receptors in human myometrial cells is accompanied by down-regulation of oxytocin receptor messenger RNA. J Endocrinol 154: 7-18. (Pubitemid 27304342)
36. Premont RT, Gainetdinov RR, (2007). Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol 69: 511-534. (Pubitemid 46457653)
37. Ren XR, Reiter E, Ahn S, Kim J, Chen W, Lefkowitz RJ, (2005). Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor. Proc Natl Acad Sci U S A 102: 1448-1453. (Pubitemid 40209190)
38. 1MF-2 cells. Br J Pharmacol 133: 1378-1386. (Pubitemid 32783500)
39. Rudolph MI, Reinicke K, Cruz MA, Gallardo V, Gonzalez C, Bardisa L, (1993). Distribution of mast cells and the effect of their mediators on contractility in human myometrium. Br J Obstet Gynaecol 100: 1125-1130. (Pubitemid 24003624)
40. Sanborn BM, (2000). Relationship of ion channel activity to control of myometrial calcium. J Soc Gynecol Investig 7: 4-11. (Pubitemid 30109318)
41. Sanborn BM, (2001). Hormones and calcium: mechanisms controlling uterine smooth muscle contractile activity. The Litchfield Lecture. Exp Physiol 86: 223-237. (Pubitemid 32266457)
42. Sanborn BM, (2007). Hormonal signaling and signal pathway crosstalk in the control of myometrial calcium dynamics. Semin Cell Dev Biol 18: 305-314. (Pubitemid 47211990)
43. Simon V, Robin MT, Legrand C, Cohen-Tannoudji J, (2003). Endogenous G protein-coupled receptor kinase 6 triggers homologous beta-adrenergic receptor desensitization in primary uterine smooth muscle cells. Endocrinology 144: 3058-3066. (Pubitemid 36819908)
44. Smith MP, Ayad VJ, Mundell SJ, McArdle CA, Kelly E, Lopez Bernal A, (2006). Internalization and desensitization of the oxytocin receptor is inhibited by Dynamin and clathrin mutants in human embryonic kidney 293 cells. Mol Endocrinol 20: 379-388. (Pubitemid 43152511)
45. Sun Y, Cheng Z, Ma L, Pei G, (2002). β-arrestin2 is critically involved in CXCR4-mediated chemotaxis, and this is mediated by its enhancement of p38 MAPK activation. J Biol Chem 277: 49212-49219. (Pubitemid 36014350)
46. Tobin AB, Butcher AJ, Kong KC, (2008). Location, location, location. site-specific GPCR phosphorylation offers a mechanism for cell-type-specific signalling. Trends Pharmacol Sci 29: 413-420.
47. 3 muscarinic acetylcholine receptor in human SH-SY5Y cells. Mol Pharmacol 60: 321-330. (Pubitemid 32678297)
48. Willets JM, Challiss RA, Nahorski SR, (2003). Non-visual GRKs: are we seeing the whole picture? Trends Pharmacol Sci 24: 626-633. (Pubitemid 37494784)
49. 1 muscarinic acetylcholine receptors by G protein-coupled receptor kinase 2 in hippocampal neurons. J Biol Chem 280: 18950-18958. (Pubitemid 41379598)
50. 1 histamine receptor signaling by G protein-coupled receptor kinase 2 in uterine smooth muscle cells. Mol Endocrinol 22: 1893-1907.
51. Willets JM, Brighton PJ, Mistry R, Morris GE, Konje JC, Challiss RA, (2009). Regulation of oxytocin receptor responsiveness by G protein-coupled receptor kinase 6 in human myometrial smooth muscle. Mol Endocrinol 23: 1272-1280.
52. Yuan W, Lopez Bernal A, (2007). Cyclic AMP signalling pathways in the regulation of uterine relaxation. BMC Pregnancy Childbirth 7: S10.
53. Zhao M, Wimmer A, Trieu K, Discipio RG, Schraufstatter IU, (2004). Arrestin regulates MAPK activation and prevents NADPH oxidase-dependent death of cells expressing CXCR2. J Biol Chem 279: 49259-49267. (Pubitemid 39625811)
54. qGβγ and epidermal growth factor receptor tyrosine kinase activation. Endocrinology 144: 2947-2956. (Pubitemid 36819897)
55. Zingg HH, Laporte SA, (2003). The oxytocin receptor. Trends Endocrinol Metab 14: 222-227. (Pubitemid 36841480)